Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 31 December 2018

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 75 Euro (EUR) 11 Other currencies (CAD, DKK, INR, SEK) 7 British pound (GBP) 3 Swiss franc (CHF) 4 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Public companies 48 Private companies 27 Funds 10 Cash and cash equivalents 12 Other assets 3 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Products on the market 24 Phase III 32 Phase II 26 Profitable 12 Phase I 5 Preclinical 1 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 28 Oncology 15 Orphan diseases 22 Central nervous system 10 Medical technology / diagnostics 5 Digital Health 5 Autoimmune diseases 7 Metabolic diseases 5 Infectious diseases 3 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A